Document is current

Article History

Accepted: 13 November 2024

First Online: 29 December 2024

Declarations

:

: MS is a consultant for Abbvie, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Fresenius Kabi, Galapagos, Innate Pharma, Nordic Pharma, Novartis, Sandoz. JA received honoraria from Galapagos, Lilly, Pfizer, Abbvie, Bristol-Myers Squibb, Sanofi, Roche-Chugai, Nordic Pharma, Medac, Novartis, Biogen, Fresenius Kabi, Janssen, and MSD; and research grants from Bristol-Myers Squibb, Pfizer (Passerelle), Novartis (Dreamer), Fresenius Kabi, Galapagos, Nordic Pharma.

: None.

: JA conceived and planned the review; conducted the literature search and data synthesis; wrote the majority of the manuscript and coordinated final revisions. MS contributed to the literature search; provided suggestions and improvements to the manuscript structure; reviewed and validated scientific content; participated in final revisions for approval.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.